Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Dua is a Clinical Associate Professor of Surgery at Stanford. She received her undergraduate degree from the University of California, Los Angeles and her medical degree from Drexel University in Philadelphia. She completed her general surgery residency at Stanford University School of Medicine with a two year post-doctoral research fellowship in vascular biology. She then went on to do a one year fellowship in minimally invasive and robotic surgery at the Cleveland Clinic and a second two year fellowship in hepatobiliary and pancreatic surgery back at Stanford University prior to joining the division faculty. Her clinical specialty is in hepatobiliary and gastrointestinal oncology with a primary focus on benign and malignant disease of the liver, pancreas, and bile duct including disease processes of pancreatic cancer, pancreatitis, colorectal cancer liver metastases, bile duct cancer, bile duct injuries, choledochal cysts, and hepatocellular carcinoma of the liver. She also performs oncologic resections for sarcomas, tumors of the distal esophagus, stomach, and small intestine, and all neuroendocrine tumors. Dr. Dua is able to perform many of her operations in a minimally invasive manner including robotic pancreatic resections and laparoscopic operations of the liver.Dr. Dua is an active instructor in the Stanford University surgical clerkship curriculum for medical students and also serves as the regional HPB Surgeon at the VA Palo Alto Health Care System. Dr. Dua is an active member of multiple surgical societies, she is on the Diversity, Equity, and Inclusion cabinet at Stanford, the training and education committee of the Americas Hepato-Pancreato-Biliary Association, and serves as the associate program director for the HPB fellowship, and the associate program director of the Stanford general surgery residency. She participates in the Benign Pancreas Program at Stanford and her research includes both benign and malignant aspects of GI/HPB surgery with a focus on the management of severe pancreatitis as well as surgical strategies for the treatment of necrotizing pancreatitis. Other research interests include the application of minimally invasive approaches to the surgical management of HPB diseases including laparoscopic techniques in liver surgery and the use of laparoscopic and robotic platforms in pancreatic surgery. She completed a clinical trial looking at the myoelectric activity of the stomach and intestine following pancreaticoduodenectomy as a function of predicting which patients are at higher risk of developing delayed gastric emptying or postoperative ileus. This study was performed concurrently with the introduction of the division’s enhanced recovery after surgery perioperative care pathways to facilitate improved patient outcomes in those undergoing pancreatic resections and she actively reviews and improves these ERAS pathways for both pancreas and liver operations at Stanford.
Technical aspects of minimally invasive pancreatic and liver surgery<br/>Minimally invasive strategies for the management of pancreatic necrosis<br/>Management of severe acute pancreatitis – academic vs community treatment <br/>Multidisciplinary treatment of HCC; institutional barriers to appropriate referral/ care<br/>Endocrine/exocrine insufficiency after pancreatectomy; volumetric assessment<br/>Natural history and management of pancreatic cysts